NO20061788L - HIV-replikasjonshemmede purinderivater - Google Patents
HIV-replikasjonshemmede purinderivaterInfo
- Publication number
- NO20061788L NO20061788L NO20061788A NO20061788A NO20061788L NO 20061788 L NO20061788 L NO 20061788L NO 20061788 A NO20061788 A NO 20061788A NO 20061788 A NO20061788 A NO 20061788A NO 20061788 L NO20061788 L NO 20061788L
- Authority
- NO
- Norway
- Prior art keywords
- formula
- radical
- hiv replication
- purine derivatives
- compound
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/16—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/18—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP0350659 | 2003-09-25 | ||
PCT/EP2004/052262 WO2005028479A2 (en) | 2003-09-25 | 2004-09-21 | Hiv replication inhibiting purine derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20061788L true NO20061788L (no) | 2006-04-24 |
Family
ID=34354400
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20061788A NO20061788L (no) | 2003-09-25 | 2006-04-24 | HIV-replikasjonshemmede purinderivater |
Country Status (19)
Country | Link |
---|---|
US (1) | US8026245B2 (es) |
EP (1) | EP1668011B1 (es) |
JP (1) | JP5506751B2 (es) |
KR (1) | KR20060121878A (es) |
CN (1) | CN100475815C (es) |
AP (1) | AP2006003517A0 (es) |
AT (1) | ATE500254T1 (es) |
AU (1) | AU2004274185B2 (es) |
BR (1) | BRPI0414791A (es) |
CA (1) | CA2535313C (es) |
DE (1) | DE602004031641D1 (es) |
EA (1) | EA009734B1 (es) |
ES (1) | ES2361835T3 (es) |
IL (1) | IL174467A0 (es) |
MX (1) | MXPA06002069A (es) |
NO (1) | NO20061788L (es) |
TW (1) | TW200518758A (es) |
WO (1) | WO2005028479A2 (es) |
ZA (1) | ZA200602440B (es) |
Families Citing this family (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI329105B (en) | 2002-02-01 | 2010-08-21 | Rigel Pharmaceuticals Inc | 2,4-pyrimidinediamine compounds and their uses |
MXPA05001096A (es) | 2002-07-29 | 2005-11-23 | Rigel Pharmaceuticals Inc | Metodos para tratamiento o prevencion de enfermedades autoinmunes con compuestos de 2,4-diamino-pirimidina. |
NZ545270A (en) | 2003-07-30 | 2010-04-30 | Rigel Pharmaceuticals Inc | 2,4-Pyrimidinediamine compounds for use in the treatment or prevention of autoimmune diseases |
US20070197559A1 (en) * | 2004-03-02 | 2007-08-23 | Rajagopal Bakthavatchalam | Aryl substituted purine analogues |
WO2007050087A1 (en) | 2004-08-25 | 2007-05-03 | Ardea Biosciences, Inc. | N[S(4-aryl-triazol-3-yl)α -mercaptoacetyl]-p-amino benozoic acids AS HIV REVERSE TRANSCRIPTASE INHIBITORS |
DK2135608T3 (da) | 2004-08-25 | 2012-01-23 | Ardea Biosciences Inc | S-triazolyl-alfa-mercaptoacetanilider som inhibitorer for HIV-revers transkriptase |
CA2580787A1 (en) | 2004-09-20 | 2006-03-30 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-coa desaturase enzymes |
CA2580857A1 (en) | 2004-09-20 | 2006-09-28 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors |
BRPI0515505A (pt) | 2004-09-20 | 2008-07-29 | Xenon Pharmaceuticals Inc | derivados heterocìclicos e sua utilização como inibidores da estearoil-coa desaturase |
TW200626138A (en) | 2004-09-20 | 2006-08-01 | Xenon Pharmaceuticals Inc | Heterocyclic derivatives and their use as therapeutic agents |
CA2580845A1 (en) | 2004-09-20 | 2006-03-30 | Xenon Pharmaceuticals Inc. | Pyridazine derivatives for inhibiting human stearoyl-coa-desaturase |
EP1799668A1 (en) | 2004-09-20 | 2007-06-27 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as mediators of stearoyl-coa desaturase |
EP1799664A1 (en) | 2004-09-20 | 2007-06-27 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors |
KR20080004550A (ko) | 2005-03-30 | 2008-01-09 | 콘포마 세러퓨틱스 코포레이션 | Hsp90-억제제로서 알키닐 피롤로피리미딘 및 관련유사체 |
ATE541848T1 (de) * | 2005-05-05 | 2012-02-15 | Ardea Biosciences Inc | Diaryl-purin, azapurine und deazapurine als nichtnukleoside reverse-transkriptase-inhibitoren zur behandlung von hiv |
JP5108752B2 (ja) * | 2005-05-16 | 2012-12-26 | プロメティック・バイオサイエンスィズ・インコーポレーテッド | 自己免疫疾患を治療するための化合物とそれら化合物の使用 |
US8541457B2 (en) | 2005-06-03 | 2013-09-24 | Xenon Pharmaceuticals Inc. | Aminothiazole derivatives as human stearoyl-CoA desaturase inhibitors |
NZ563454A (en) | 2005-06-08 | 2011-03-31 | Rigel Pharmaceuticals Inc | 2,4-diaminopyrimidine derivatives for inhibition of the JAK pathway |
US20070203161A1 (en) | 2006-02-24 | 2007-08-30 | Rigel Pharmaceuticals, Inc. | Compositions and methods for inhibition of the jak pathway |
US8962643B2 (en) | 2006-02-24 | 2015-02-24 | Rigel Pharmaceuticals, Inc. | Compositions and methods for inhibition of the JAK pathway |
EP2132211A4 (en) * | 2006-11-09 | 2011-12-07 | Ardea Biosciences Inc | 4-CYANPHENYLAMINO-SUBSTITUTED BICYCLIC AND HETEROCYCLIC COMPOUNDS AS AN HIV HEMMER |
CA2677096A1 (en) | 2007-01-31 | 2008-08-07 | Vertex Pharmaceuticals Incorporated | Kinase inhibitors |
US8084483B2 (en) | 2007-11-27 | 2011-12-27 | Ardea Biosciences, Inc. | Compounds and compositions and methods of use |
ES2389752T3 (es) | 2007-12-14 | 2012-10-31 | Ardea Biosciences, Inc. | Inhibidores de la transcriptasa inversa |
JP2011529062A (ja) | 2008-07-23 | 2011-12-01 | バーテックス ファーマシューティカルズ インコーポレイテッド | ピラゾロピリジンキナーゼ阻害剤 |
CN102131809A (zh) | 2008-07-23 | 2011-07-20 | 沃泰克斯药物股份有限公司 | 三环吡唑并吡啶激酶抑制剂 |
US8569337B2 (en) | 2008-07-23 | 2013-10-29 | Vertex Pharmaceuticals Incorporated | Tri-cyclic pyrazolopyridine kinase inhibitors |
CN102159546A (zh) | 2008-08-06 | 2011-08-17 | 沃泰克斯药物股份有限公司 | 氨基吡啶激酶抑制剂 |
JP5627675B2 (ja) | 2009-05-06 | 2014-11-19 | バーテックス ファーマシューティカルズ インコーポレイテッドVertex Pharmaceuticals Incorporated | ピラゾロピリジン |
US8828990B2 (en) | 2009-11-12 | 2014-09-09 | Genentech, Inc. | N-7 substituted purine and pyrazolopyrimine compounds, compositions and methods of use |
MX2012008644A (es) | 2010-01-27 | 2012-11-23 | Vertex Pharma | Inhibidores de cinasa de pirazolopiridinas. |
CN102869663A (zh) | 2010-01-27 | 2013-01-09 | 沃泰克斯药物股份有限公司 | 吡唑并吡嗪激酶抑制剂 |
CA2787363A1 (en) | 2010-01-27 | 2011-08-04 | Vertex Pharmaceuticals Incorporated | Pyrazolopyrimidine kinase inhibitors |
US20140018379A1 (en) | 2010-02-18 | 2014-01-16 | Concert Pharmaceuticals Inc. | Pyrimidine derivatives |
FR2962437B1 (fr) | 2010-07-06 | 2012-08-17 | Sanofi Aventis | Derives d'imidazopyridine, leur procede de preparation et leur application en therapeutique |
FR2962438B1 (fr) | 2010-07-06 | 2012-08-17 | Sanofi Aventis | Derives d'indolizines, procedes de preparation et application en therapeutique |
CN103570688B (zh) * | 2012-07-19 | 2016-06-08 | 中国科学院上海药物研究所 | 2,5-二氨甲基吡嗪类化合物、其药物组合物、制备方法和用途 |
US10016439B2 (en) | 2014-01-31 | 2018-07-10 | Ono Pharmaceutical Co., Ltd. | Fused imidazole compounds |
MX2017008075A (es) | 2014-12-18 | 2017-11-16 | Nissan Chemical Ind Ltd | Compuesto de cetona u oxima, y herbicida. |
WO2018075937A1 (en) | 2016-10-21 | 2018-04-26 | Nimbus Lakshmi, Inc. | Tyk2 inhibitors and uses thereof |
EP3870568B1 (en) * | 2018-10-25 | 2023-06-28 | Minakem | Process for the preparation of rilpivirine |
CN110526873B (zh) * | 2019-08-15 | 2022-09-16 | 复旦大学 | 氰乙烯基取代的苯并二芳基嘧啶类化合物及其制备方法和用途 |
CN114805369B (zh) * | 2022-05-30 | 2023-05-16 | 自贡市第四人民医院(自贡市急救中心) | 一种2,6-二取代嘌呤类化合物及制备方法及应用 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3459731A (en) * | 1966-12-16 | 1969-08-05 | Corn Products Co | Cyclodextrin polyethers and their production |
NZ322907A (en) | 1995-11-23 | 1998-12-23 | Janssen Pharmaceutica Nv | Solid mixtures of cyclodextrins prepared via melt-extrusion |
US5866702A (en) * | 1996-08-02 | 1999-02-02 | Cv Therapeutics, Incorporation | Purine inhibitors of cyclin dependent kinase 2 |
CN1214014C (zh) | 1998-03-27 | 2005-08-10 | 詹森药业有限公司 | 抑制hiv的嘧啶衍生物 |
HU230394B1 (hu) * | 1998-11-10 | 2016-04-28 | Janssen Pharmaceutica N.V. | HIV-vírus szaporodását gátló pirimidin-származékok |
US6414147B1 (en) * | 1998-12-23 | 2002-07-02 | Neurogen Corporation | 2-amino-9-alkylpurines: GABA brain receptor ligands |
CZ27399A3 (cs) * | 1999-01-26 | 2000-08-16 | Ústav Experimentální Botaniky Av Čr | Substituované dusíkaté heterocyklické deriváty, způsob jejich přípravy, tyto deriváty pro použití jako léčiva, farmaceutická kompozice a kombinovaný farmaceutický přípravek tyto deriváty obsahující a použití těchto derivátů pro výrobu léčiv |
GB9918035D0 (en) * | 1999-07-30 | 1999-09-29 | Novartis Ag | Organic compounds |
IL150594A0 (en) | 2000-01-07 | 2003-02-12 | Ustav Ex Botan Adademie Ved Ce | Purine derivatives, process for their preparation and use |
JO3429B1 (ar) | 2001-08-13 | 2019-10-20 | Janssen Pharmaceutica Nv | مشتقات برميدينات مثبطة فيروس الايدز |
US6897307B2 (en) * | 2002-03-28 | 2005-05-24 | Novartis Ag | Process for preparing 2,6-diaminopurine derivatives |
CA2535620A1 (en) * | 2003-08-15 | 2005-02-24 | Irm Llc | 6-substituted anilino purines as rtk inhibitors |
ATE541848T1 (de) * | 2005-05-05 | 2012-02-15 | Ardea Biosciences Inc | Diaryl-purin, azapurine und deazapurine als nichtnukleoside reverse-transkriptase-inhibitoren zur behandlung von hiv |
-
2004
- 2004-09-21 US US10/573,364 patent/US8026245B2/en not_active Expired - Fee Related
- 2004-09-21 AP AP2006003517A patent/AP2006003517A0/xx unknown
- 2004-09-21 WO PCT/EP2004/052262 patent/WO2005028479A2/en active Application Filing
- 2004-09-21 AT AT04766834T patent/ATE500254T1/de not_active IP Right Cessation
- 2004-09-21 CN CNB2004800278401A patent/CN100475815C/zh not_active Expired - Fee Related
- 2004-09-21 EP EP04766834A patent/EP1668011B1/en active Active
- 2004-09-21 ES ES04766834T patent/ES2361835T3/es active Active
- 2004-09-21 BR BRPI0414791-0A patent/BRPI0414791A/pt not_active Application Discontinuation
- 2004-09-21 AU AU2004274185A patent/AU2004274185B2/en not_active Ceased
- 2004-09-21 KR KR1020067005328A patent/KR20060121878A/ko not_active Application Discontinuation
- 2004-09-21 EA EA200600648A patent/EA009734B1/ru not_active IP Right Cessation
- 2004-09-21 DE DE602004031641T patent/DE602004031641D1/de active Active
- 2004-09-21 MX MXPA06002069A patent/MXPA06002069A/es active IP Right Grant
- 2004-09-21 CA CA2535313A patent/CA2535313C/en not_active Expired - Fee Related
- 2004-09-24 TW TW093128936A patent/TW200518758A/zh unknown
-
2006
- 2006-03-21 IL IL174467A patent/IL174467A0/en active IP Right Grant
- 2006-03-24 ZA ZA200602440A patent/ZA200602440B/en unknown
- 2006-04-24 NO NO20061788A patent/NO20061788L/no not_active Application Discontinuation
-
2011
- 2011-08-01 JP JP2011168572A patent/JP5506751B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
AU2004274185A1 (en) | 2005-03-31 |
CN100475815C (zh) | 2009-04-08 |
EA200600648A1 (ru) | 2006-08-25 |
EP1668011B1 (en) | 2011-03-02 |
JP4825672B2 (ja) | 2011-11-30 |
BRPI0414791A (pt) | 2006-11-21 |
US8026245B2 (en) | 2011-09-27 |
US20060293330A1 (en) | 2006-12-28 |
EP1668011A2 (en) | 2006-06-14 |
MXPA06002069A (es) | 2006-05-19 |
WO2005028479A3 (en) | 2005-06-16 |
JP5506751B2 (ja) | 2014-05-28 |
ATE500254T1 (de) | 2011-03-15 |
AU2004274185B2 (en) | 2009-12-10 |
JP2012006945A (ja) | 2012-01-12 |
ES2361835T3 (es) | 2011-06-22 |
DE602004031641D1 (de) | 2011-04-14 |
ZA200602440B (en) | 2007-09-26 |
AP2006003517A0 (en) | 2006-02-28 |
CA2535313C (en) | 2012-07-17 |
JP2007506707A (ja) | 2007-03-22 |
EA009734B1 (ru) | 2008-02-28 |
CN1856496A (zh) | 2006-11-01 |
CA2535313A1 (en) | 2005-03-31 |
TW200518758A (en) | 2005-06-16 |
IL174467A0 (en) | 2006-08-01 |
WO2005028479A2 (en) | 2005-03-31 |
KR20060121878A (ko) | 2006-11-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20061788L (no) | HIV-replikasjonshemmede purinderivater | |
NO20054905L (no) | 2-acylamino-4-fenyltiazolderivater, fremgangsmate for deres fremstilling og anvendelse av de samme som i terapeutika | |
GB0612423D0 (en) | Therapeutic agents | |
NO20072689L (no) | Tetrasykliske indolderivater som antivirale midler | |
NO20021328L (no) | Pyrazolopyrimidier som terapeutiske midler | |
NO20060974L (no) | Pyridazinderivater og deres anvendelse som terapeutiske midler | |
NO20050088L (no) | Kationisk substituerte difenylazefidinoner, fremgangsmate for deres fremstilling, medikamenter inneholdende nevnte forbindelser og anvendelse derav | |
NO20060973L (no) | Pyridylderivater og deres anvendelse som tempeutiske midler | |
CY1105362T1 (el) | Παραγωγα σουλφοναμιδιου, η παρασκευη τους και η εφαρμογη αυτων ως φαρμακα | |
NO20054143L (no) | Pyrimidinderivater for forhindringen av HIV-infeksjon | |
DE602004024375D1 (de) | Carboxamidderivate | |
NO20070224L (no) | 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav | |
WO2006027628A3 (en) | Naphthalimide derivatives as antiviral agents | |
CY1109497T1 (el) | Παραγωγα θειοφενιου ως αντιβιοτικοι παραγοντες για λοιμωξη/μολυνση φλαβοϊου (flavivirus) | |
NO20081844L (no) | Terapeutiske forbindelser | |
BR0316771A (pt) | Compostos para o tratamento ou a prevenção de infecções por flavivirus, uso de um composto e composição farmacêutica | |
NO20050666L (no) | 2,7-substituerte indoler og deres anvendelse som 5-HT6 modulatorer | |
GB0413087D0 (en) | Therapeutic compounds | |
NO20072515L (no) | 2-amido-4-fenyltnazolderivater, fremstilling og terapeutsik anvendelse derav | |
NO20070837L (no) | Pyrido-pyrido pyrimidinderivater, fremstilling derav samt terapeutisk anvendelse for behandling av cancer. | |
NO20062491L (no) | Benzoksazinderivter og deres anvendelse | |
TNSN04203A1 (en) | Benzoxazinone-derived compounds, their preparation and use as medicaments | |
SE0202429D0 (sv) | Novel Compounds | |
DK2040703T3 (da) | Derivater af 2-benzoylimidazopyridiner, fremstilling deraf og terapeutisk anvendelse deraf | |
MXPA04006041A (es) | Antivirales de piridoquinoxalina. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |